Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
Abstract
// Eleftherios P. Samartzis 1 , Katrin Gutsche 1 , Konstantin J. Dedes 1 , Daniel Fink 1 , Manuel Stucki 1 and Patrick Imesch 1 1 Department of Gynecology, University Hospital of Zurich, Zürich, Switzerland Correspondence: Patrick Imesch, email: // Keywords : ARID1A; BAF250a; SWI/SNF; PI3K/AKT pathway; AKT phosphorylation; PIK3CA; apoptosis; AKT-inhibitor; MK-2206; perifosine; PI3K-inhibitor; buparlisib (BKM120); ovarian clear cell...
Paper Details
Title
Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition
Published Date
Jun 11, 2014
Journal
Volume
5
Issue
14
Pages
5295 - 5303
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History